Hostname: page-component-5d84bcc8dc-qvhhc Total loading time: 0 Render date: 2026-09-13T11:41:55.146Z Has data issue: false hasContentIssue false
  • English
  • Français

Denominator Matters in Estimating Antimicrobial Use: A Comparison of Days Present and Patient Days

Published online by Cambridge University Press:  26 March 2018

Rebekah W. Moehring ,
Elizabeth S. Dodds Ashley ,
Xinru Ren ,
Yuliya Lokhnygina ,
Arthur W. Baker ,
Travis M. Jones ,
Sarah S. Lewis ,
Daniel J. Sexton ,
Deverick J. Anderson  and
the Centers for Disease Control and Prevention Epicenters Program
Rebekah W. Moehring*
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Elizabeth S. Dodds Ashley
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Xinru Ren
Affiliation:
Department of Biostatistics, Duke University, Durham, North Carolina
Yuliya Lokhnygina
Affiliation:
Department of Biostatistics, Duke University, Durham, North Carolina
Arthur W. Baker
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Travis M. Jones
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Sarah S. Lewis
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Daniel J. Sexton
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
Deverick J. Anderson
Affiliation:
Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University, Durham, North Carolina
*
Address correspondence to Rebekah W. Moehring, MD, MPH, Duke University Medical Center, 315 Trent Drive, Durham, NC, 27705 (rebekah.moehring@duke.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

Patient days and days present were compared to directly measured person time to quantify how choice of different denominator metrics may affect antimicrobial use rates. Overall, days present were approximately one-third higher than patient days. This difference varied among hospitals and units and was influenced by short length of stay.

Infect Control Hosp Epidemiol 2018;39:612–615

Information

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 5 , May 2018 , pp. 612 - 615
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1. Pollack, LA, Srinivasan, A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014;59(Suppl 3):S97–S100.CrossRefGoogle ScholarPubMed
2. Polk, RE, Fox, C, Mahoney, A, Letcavage, J, MacDougall, C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664–670.Google Scholar
3. Morris, AM, Brener, S, Dresser, L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012;33:500–506.Google Scholar
4. Moehring, RW, Anderson, DJ, Cochran, RL, Hicks, LA, Srinivasan, A, Dodds Ashley, E. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute care settings. Clin Infect Dis 2017;64:377–383.CrossRefGoogle ScholarPubMed
5. Ibrahim, OM, Polk, RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin N Am 2014;28:195–214.Google Scholar
6. National Healthcare Safety Network. MDRO Module. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Updated January 2018. Accessed February 21, 2018.Google Scholar
7. National Healthcare Safety Network. Antimicrobial use and resistance (AUR) options. Centers for Disease Control and Prevention website.http://www.cdc.gov/nhsn/acute-care-hospital/aur/index.html. Updated February 8, 2018. Accessed February 21, 2018.Google Scholar
8. Anderson, DJ, Chen, LF, Weber, DJ, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection Study): a cluster-randomised, multicentre, crossover study. Lancet (London) 2017;389:805–814.Google Scholar
9. Locations and descriptions and instructions for mapping patient care locations. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/15locationsdescriptions_current.pdf. Published 2013. Accessed February 15, 2018.Google Scholar
10. Stenehjem, E, Hersh, AL, Sheng, X, et al. Antibiotic use in small community hospitals. Clin Infect Dis 2016;63:1273–1280.CrossRefGoogle ScholarPubMed
Supplementary material: File

Moehring et al. supplementary material

Moehring et al. supplementary material 1

Download Moehring et al. supplementary material(File)
File 15.1 KB